Taysha Gene Therapies, Inc. TSHA Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Taysha Gene Therapies, Inc.’s reported figures.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s free cash flow?
- Taysha Gene Therapies, Inc. (TSHA) reported free cash flow of -$40.9M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s free cash flow changed year-over-year?
- Taysha Gene Therapies, Inc.'s free cash flow decreased by 82.6% year-over-year, from -$22.4M to -$40.9M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s free cash flow?
- Over 3 years (2021 to 2025), Taysha Gene Therapies, Inc.'s free cash flow has grown at a -10.8% compound annual growth rate (CAGR), from -$132.35M to -$93.83M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.